Drug Type Universal CAR-T |
Synonyms- |
Target |
Action inhibitors |
Mechanism CD19 inhibitors(B-lymphocyte antigen CD19 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Churg-Strauss Syndrome | Phase 2 | Italy | - | 29 Nov 2024 |
Dermatomyositis | Phase 2 | Italy | - | 29 Nov 2024 |
Diffuse Cerebral Sclerosis of Schilder | Phase 2 | Italy | - | 29 Nov 2024 |
Granulomatosis With Polyangiitis | Phase 2 | Italy | - | 29 Nov 2024 |
Microscopic Polyangiitis | Phase 2 | Italy | - | 29 Nov 2024 |
Scleroderma, Systemic | Phase 2 | Italy | - | 29 Nov 2024 |
Systemic Lupus Erythematosus | Phase 2 | Italy | - | 29 Nov 2024 |
CD19-positive B-cell acute lymphoblastic leukemia | Phase 1 | Italy | 28 Apr 2024 | |
Pre B-cell acute lymphoblastic leukemia | Phase 1 | Italy | 28 Apr 2024 |